Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human”
1,164 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,164 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12172038
Anti-coronavirus antibodies and methods of use
granted -
US 12171818
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
granted -
US 12168802
Methods of diagnosing and treating CD55 deficiency, hyperactivation of complement, angiopathic thrombosis and protein losing enteropathy (CHAPLE), a newly identified orphan disease
granted -
US 12168008
Oxabicycloheptanes for modulation of immune response
granted -
US 12168675
Virus-like particles and methods of use
granted -
US 12162910
Recombinant gp120 protein with V1-loop deletion
granted -
US 12162861
Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof
granted -
US 12161733
Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer
granted -
US 12157762
Tethered interleukin-15 and interleukin-21
granted -
US 12145922
Selective D3 dopamine receptor agonists and methods of their use
granted -
US 12145968
Recombinant HIV-1 envelope proteins and their use
granted -
US 12122843
High affinity monoclonal antibodies targeting glypican-1 and methods of use
granted -
US 12102671
Method of vaccination with an attenuated RSV vaccine formulation
granted -
US 12097196
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof
granted -
US 12084489
Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection
granted -
US 12083246
Composite gels and methods of use thereof
granted -
US 12077572
Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof
granted -
US 12071632
Chimeric vectors
granted -
US 12064514
Ultrasound-sensitive peptide particles for spatially resolved molecule delivery
granted -
US 12059413
Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction
granted -
US 12059418
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
granted -
US 12054749
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
granted -
US 12053520
Glycan-masked engineered outer domains of HIV-1 gp120 and their use
granted -
US 12053519
HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
granted